Walgreens Boots Alliance Inc.（NASDAQ：WBA）超過了分析師的期望，其第一季度表現

Walgreens Boots Alliance Inc.（NASDAQ：WBA）在截至2024年11月30日的時期發表了出色的第一季度表演

Nasdaq-listed Walgreens Boots Alliance Inc. (Nasdaq: WBA) reported better-than-expected first-quarter earnings on Friday, thanks to a combination of cost-cutting measures and a boost from its U.S. health care segment. Walgreens’ stock soared as much as 28% in early Friday trading, reaching $11.77.

納斯達克上市的Walgreens Boots Alliance Inc.（NASDAQ：WBA）在周五報告了比預期的第一季度收益，這要歸功於削減成本措施和美國醫療保健領域的提高。沃爾格林（Walgreens）的股票在周五早些時候交易中飆升了多達28％，達到11.77美元。

Walgreens battered investors with a loss per share for the first quarter that ended on November 30, 2024. Adjusted for one-time items, Walgreens earned 51 cents per share in Q1. Analysts, on average, had anticipated adjusted earnings of 38 cents per share for the recent quarter.

沃爾格林（Walgreens）毆打投資者，在2024年11月30日結束的第一季度每股虧損。對一次性物品進行了調整，沃爾格林斯（Walgreens）在第一季度的每股51美分。平均而言，分析師預計最近一個季度的調整後每股收益為38美分。

In the prior quarter (Q4), Walgreens had recorded adjusted earnings of 84 cents per share.

在上一季度（第四季度）中，沃爾格林（Walgreens）記錄了調整後的每股84美分的調整收益。

Walgreens Boots went past expectations on the revenue front as well with a 7% year-over-year increase that pushed sales to $39.5 billion in the first quarter. As per FactSet, analysts had прогнозировал продажи на уровне $38.6 billion for the recent quarter.

沃爾格林·靴子（Walgreens Boots）在收入方面的預期也超過了期望，同比增長7％，將銷售額提高到第一季度的395億美元。根據FACTSET，分析師在最近一個季度中具有386億美元的386億美元。

The U.S. health care segment noted a 7.4% organic sales growth in Q1, as reported earlier by the company. Walgreens also highlighted a ‘double-digit’ growth from its clinic services, partnerships, and digital health initiatives.

美國醫療保健領域指出，正如該公司之前報導的那樣，第1季度有機銷售增長了7.4％。沃爾格林還強調了其診所服務，合作夥伴關係和數字健康計劃的“雙位”增長。

In a bid to execute on its strategic priorities for 2025, Walgreens closed the quarter with 5,440 retail pharmacies in the United States. The company also optimized its footprint by reducing the number of stores to 8,495, including 340 owned by Kroger Co. (NYSE: KR).

為了執行2025年的戰略重點，沃爾格林在美國以5,440家零售藥店結束了該季度。該公司還通過將商店數量減少到8,495，其中包括克羅格公司（Kroger Co.）（NYSE：KR）擁有的340個，從而優化了其足跡。

Walgreens now aims to close 1,200 retail stores in the United States, with 500 scheduled for closure in fiscal 2025 and the remaining closures spread out over the next three years.

沃爾格林（Walgreens）現在的目標是關閉美國的1200家零售商店，預定在2025財年關閉500家，並在未來三年內分佈在2025年。

Walgreens stock performed poorly in 2023 with a close to 40% annual decline. At the time of writing, the stock is valued at $40.1 billion and has a price to earnings ratio of 48.6

沃爾格林（Walgreens）的股票在2023年的每年下降近40％。在撰寫本文時，該股票的價值為401億美元，其收入率為48.6